Prophylactic infusion of leukaemia-reactive donor T-cells to prevent relapse of chronic myeloid leukaemia after CD34+selected allogeneic haematopoietic cell transplantation

被引：0

作者：

Bornhäuser, M ^{[1
]}

Babatz, J ^{[1
]}

Thiede, C ^{[1
]}

Schetelig, J ^{[1
]}

Illmer, T ^{[1
]}

Kiani, A ^{[1
]}

Helwig, A ^{[1
]}

Platzbecker, U ^{[1
]}

Rieber, P ^{[1
]}

Ehninger, G ^{[1
]}

Schmitz, M ^{[1
]}

机构：

[1] Univ Klinikum Dresden, Dresden, Germany

来源：

BONE MARROW TRANSPLANTATION | 2006年 / 37卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：S105 / S105

页数：1

共 50 条

[31] Efficacy of Donor Lymphocyte Infusion in CD34+Selected Allogeneic Hematopoietic Stem Cell Transplant for Myeloid and Lymphoid Malignancies: A Single Center Experience
Bryant, Adam
Devlin, Sean M.
Castro-Malaspina, Hugo
Jakubowski, Ann A.
Maloy, Molly
Papadopoulos, Esperanza B.
Giralt, Sergio A.
Perales, Miguel-Angel
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S303 - S304
[32] A mediastinal mass after donor lymphocyte infusion for relapse of chronic myeloid leukemia after allogeneic stem cell transplantation
Schattenberg, Anton V. M. B.
Baynes, Christopher
Van Dijk, Marcory C. R. F.
Koster, Ad
Van Cleef, Patricia H. J.
Preijers, Frank W. M. B.
Hermus, Adr.
Raemaekers, John M. M.
LEUKEMIA & LYMPHOMA, 2006, 47 (06) : 1188 - 1190
[33] Efficacy of Donor Lymphocyte Infusion in CD34+Selected Allogeneic Hematopoietic Stem Cell Transplant for Myeloid and Lymphoid Malignancies: A Single Center Experience
Bryant, Adam
Devlin, Sean M.
Castro-Malaspina, H. R.
Jakubowski, Ann A.
Maloy, Molly
Papadopoulos, Esperanza B.
Giralt, Sergio A.
Perales, Miguel-Angel
BLOOD, 2017, 130
[34] Increased CD4+CD25high+regulatory T-cell are associated with disease relapse after allogeneic stem cell transplantation (SCT) for chronic myeloid leukaemia (CML)
Nadal, E.
Kaeda, J.
Apperley, J. F.
Lechler, R.
Dazzi, F.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 15 - 15
[35] Relapse of myeloid leukemia in the donor cells following CD34-selected haploidentical stem cell transplantation
Luber, V
Thiede, C.
Haferlach, C.
Duerk, H. A.
Einsele, H.
Grigoleit, G. U.
Mielke, S.
ONKOLOGIE, 2013, 36 : 127 - 127
[36] The naive T cell subset of healthy donors can be used to expand acute myeloid leukaemia-reactive CD4+ T cells in vitro
Eichinger, Y.
Distler, E.
Schnuerer, E.
Theobald, M.
Herr, W.
ONKOLOGIE, 2011, 34 : 214 - 214
[37] Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation
YOU YongLI QiubaiCHEN ZhichaoLI WeimingXIA LinghuiZHOU Hao and ZOU Ping Institute of HaematologyUnion HospitalTongji Medical College of Huazhong University of Science and TechnologyWuhanHubei China
中华医学杂志（英文版）, 2008, (18) : 1770 - 1774
[38] Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation
You Yong
Li Qiu-bai
Chen Zhi-chao
Li Wei-ming
Xia Ling-hui
Zhou Hao
Zou Ping
CHINESE MEDICAL JOURNAL, 2008, 121 (18) : 1770 - 1774
[39] Haematopoietic chimerism status may predict relapse after in vitro T-cell depleted allogeneic stem cell transplantation for acute leukaemia
Baas, I
Marijt, W
Barge, R
Starrenburg, I
Willemze, R
Falkenburg, J
BONE MARROW TRANSPLANTATION, 2004, 33 : S238 - S238
[40] Rituximab plus donor lymphocyte infusion to prevent or treat relapse for B-cell malignancies after allogeneic haematopoietic stem cell transplantation
Cavattoni, I. M.
Schieder, H.
Zabelina, T.
Bacher, U.
Ayuk, F.
Wolschke, C.
Zander, A.
Kroeger, N.
BONE MARROW TRANSPLANTATION, 2009, 43 : S213 - S214

← 1 2 3 4 5 →